Insider Selling: Cannabis Science Inc (CBIS) CFO Sells $35,669.50 in Stock
Cannabis Science Inc (OTCMKTS:CBIS) CFO Robert James Kane sold 1,783,475 shares of the firm’s stock in a transaction on Monday, October 10th. The stock was sold at an average price of $0.02, for a total value of $35,669.50. Following the transaction, the chief financial officer now owns 23,710,717 shares in the company, valued at approximately $474,214.34. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.
Robert James Kane also recently made the following trade(s):
- On Friday, October 14th, Robert James Kane sold 1,389,577 shares of Cannabis Science stock. The stock was sold at an average price of $0.02, for a total value of $27,791.54.
- On Tuesday, September 13th, Robert James Kane sold 2,000,000 shares of Cannabis Science stock. The stock was sold at an average price of $0.01, for a total value of $20,000.00.
Cannabis Science Inc (OTCMKTS:CBIS) opened at 0.0475 on Wednesday. The company’s market cap is $93.45 million. Cannabis Science Inc has a 1-year low of $0.01 and a 1-year high of $0.05. The firm’s 50-day moving average price is $0.02 and its 200-day moving average price is $0.02.
About Cannabis Science
Cannabis Science, Inc is engaged in medical marijuana research and development. The Company works on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. The Company is involved in the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
Receive News & Ratings for Cannabis Science Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannabis Science Inc and related companies with MarketBeat.com's FREE daily email newsletter.